Session

IBS II

GENOME-WIDE ANALYSIS OF 53,400 PEOPLE WITH IRRITABLE BOWEL SYNDROME HIGHLIGHTS SHARED PATHWAYS WITH NEUROAFFECTIVE TRAITS
GENOME-WIDE ANALYSIS OF 53,400 PEOPLE WITH IRRITABLE BOWEL SYNDROME HIGHLIGHTS SHARED PATHWAYS WITH NEUROAFFECTIVE TRAITS

EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHOEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS
EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHOEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS

PREVALENCE AND IMPACT OF OVERLAPPING ROME IV DISORDERS OF GUT-BRAIN INTERACTIONS: RESULTS OF A GLOBAL EPIDEMIOLOGY STUDY
PREVALENCE AND IMPACT OF OVERLAPPING ROME IV DISORDERS OF GUT-BRAIN INTERACTIONS: RESULTS OF A GLOBAL EPIDEMIOLOGY STUDY

ALLERGY-RELATED DISEASES DURING CHILDHOOD AND RISK OF IRRITABLE BOWEL SYNDROME AT 16 YEARS: A SWEDISH BIRTH COHORT STUDY
ALLERGY-RELATED DISEASES DURING CHILDHOOD AND RISK OF IRRITABLE BOWEL SYNDROME AT 16 YEARS: A SWEDISH BIRTH COHORT STUDY

DAILY SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A 2-WEEK PROSPECTIVE HOURLY EVALUATION
DAILY SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A 2-WEEK PROSPECTIVE HOURLY EVALUATION

ASSESSMENT OF ASCENDING COLONIC DISTENSION FOLLOWING INTRAGASTRIC ADMINISTRATION OF FRUCTANS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME VERSUS HEALTHY CONTROLS: A DOUBLE-BLIND RANDOMISED CONTROL TRIAL COMBINING GASTROINTESTINAL AND BRAIN IMAGING
ASSESSMENT OF ASCENDING COLONIC DISTENSION FOLLOWING INTRAGASTRIC ADMINISTRATION OF FRUCTANS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME VERSUS HEALTHY CONTROLS: A DOUBLE-BLIND RANDOMISED CONTROL TRIAL COMBINING GASTROINTESTINAL AND BRAIN IMAGING

ANAL SLOW WAVE ACTIVITY IN HEALTH AND FAECAL INCONTINENCE
ANAL SLOW WAVE ACTIVITY IN HEALTH AND FAECAL INCONTINENCE

TOPOGRAPHICAL DISTRIBUTION OF MICROSCOPIC COLITIS, NUMBER OF BIOPSIES NECESSARY FOR DIAGNOSIS, AND IMPORTANCE OF ORIENTATION OF PARAFFIN EMBEDDED BIOPSIES
TOPOGRAPHICAL DISTRIBUTION OF MICROSCOPIC COLITIS, NUMBER OF BIOPSIES NECESSARY FOR DIAGNOSIS, AND IMPORTANCE OF ORIENTATION OF PARAFFIN EMBEDDED BIOPSIES

FASTING SERUM C4 COMBINED WITH PRIMARY FECAL BILE ACIDS FROM A SINGLE STOOL SAMPLE IS ABLE TO DIAGNOSE PATIENTS WITH BILE ACID DIARRHEA
FASTING SERUM C4 COMBINED WITH PRIMARY FECAL BILE ACIDS FROM A SINGLE STOOL SAMPLE IS ABLE TO DIAGNOSE PATIENTS WITH BILE ACID DIARRHEA

SYSTEMATIC REVIEW WITH META-ANALYSIS OF LUBIPROSTONE FOR PATIENTS WITH CONSTIPATION
SYSTEMATIC REVIEW WITH META-ANALYSIS OF LUBIPROSTONE FOR PATIENTS WITH CONSTIPATION

ASSESSMENT OF ASCENDING COLONIC DISTENSION FOLLOWING INTRAGASTRIC ADMINISTRATION OF FRUCTANS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME VERSUS HEALTHY CONTROLS: A DOUBLE-BLIND RANDOMISED CONTROL TRIAL COMBINING GASTROINTESTINAL AND BRAIN IMAGING
ASSESSMENT OF ASCENDING COLONIC DISTENSION FOLLOWING INTRAGASTRIC ADMINISTRATION OF FRUCTANS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME VERSUS HEALTHY CONTROLS: A DOUBLE-BLIND RANDOMISED CONTROL TRIAL COMBINING GASTROINTESTINAL AND BRAIN IMAGING

IBS II

DAILY SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A 2-WEEK PROSPECTIVE HOURLY EVALUATION
DAILY SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A 2-WEEK PROSPECTIVE HOURLY EVALUATION

IBS II

IBS II - Panel discussion
IBS II - Panel discussion

GENOME-WIDE ANALYSIS OF 53,400 PEOPLE WITH IRRITABLE BOWEL SYNDROME HIGHLIGHTS SHARED PATHWAYS WITH NEUROAFFECTIVE TRAITS
GENOME-WIDE ANALYSIS OF 53,400 PEOPLE WITH IRRITABLE BOWEL SYNDROME HIGHLIGHTS SHARED PATHWAYS WITH NEUROAFFECTIVE TRAITS

IBS II

EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHOEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS
EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHOEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS

IBS II

SYSTEMATIC REVIEW WITH META-ANALYSIS OF LUBIPROSTONE FOR PATIENTS WITH CONSTIPATION
SYSTEMATIC REVIEW WITH META-ANALYSIS OF LUBIPROSTONE FOR PATIENTS WITH CONSTIPATION

IBS II

ALLERGY-RELATED DISEASES DURING CHILDHOOD AND RISK OF IRRITABLE BOWEL SYNDROME AT 16 YEARS: A SWEDISH BIRTH COHORT STUDY
ALLERGY-RELATED DISEASES DURING CHILDHOOD AND RISK OF IRRITABLE BOWEL SYNDROME AT 16 YEARS: A SWEDISH BIRTH COHORT STUDY

IBS II  et al.

PREVALENCE AND IMPACT OF OVERLAPPING ROME IV DISORDERS OF GUT-BRAIN INTERACTIONS: RESULTS OF A GLOBAL EPIDEMIOLOGY STUDY
PREVALENCE AND IMPACT OF OVERLAPPING ROME IV DISORDERS OF GUT-BRAIN INTERACTIONS: RESULTS OF A GLOBAL EPIDEMIOLOGY STUDY

IBS II  et al.

EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHOEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS
EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHOEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS

IBS II  et al.

GENOME-WIDE ANALYSIS OF 53,400 PEOPLE WITH IRRITABLE BOWEL SYNDROME HIGHLIGHTS SHARED PATHWAYS WITH NEUROAFFECTIVE TRAITS
GENOME-WIDE ANALYSIS OF 53,400 PEOPLE WITH IRRITABLE BOWEL SYNDROME HIGHLIGHTS SHARED PATHWAYS WITH NEUROAFFECTIVE TRAITS

IBS II  et al.

Item 1 - 20 / 26
1
2